Literature DB >> 25112902

Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.

N H Amr1, A Y Ahmed, Y A Ibrahim.   

Abstract

PURPOSE: Patients with congenital adrenal hyperplasia (CAH) are at increased risk for cardiovascular disease due to many factors. The aim of this study is to investigate the presence of dyslipidemia, insulin resistance, and subclinical atherosclerosis as indicated by carotid intima media thickness in children with congenital adrenal hyperplasia.
METHODS: Thirty-two children with congenital adrenal hyperplasia (3-17 years) were compared with 32 healthy controls. All underwent anthropometric evaluation, measurement of fasting lipids, glucose, insulin, oral glucose tolerance test (OGTT), homeostasis model assessment for insulin resistance (HOMA-IR), and carotid intima media thickness (CIMT).
RESULTS: Fasting glucose, glucose at 30, 60, 90, and 120 min during OGTT were significantly higher in patients. HOMA-IR was also significantly higher in patients (p = 0.036). Patients had significantly higher CIMT (p = 0.003), and higher systolic blood pressure. (p = 0.04). No significant difference existed in lipid profile. Both systolic and diastolic blood pressures correlated with treatment duration (p = 0.002, p = 0.043, respectively).
CONCLUSION: Children with CAH are at increased risk of insulin resistance, glucose intolerance, early atherosclerosis, and cardiovascular disease. Screening of these patients at an early age is recommended.

Entities:  

Mesh:

Year:  2014        PMID: 25112902     DOI: 10.1007/s40618-014-0148-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Anne Bachelot; Geneviève Plu-Bureau; Elisabeth Thibaud; Kathleen Laborde; Graziella Pinto; Dinane Samara; Claire Nihoul-Fékété; Frédérique Kuttenn; Michel Polak; Philippe Touraine
Journal:  Horm Res       Date:  2006-12-14

2.  Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.

Authors:  Nike M M L Stikkelbroeck; Wim J G Oyen; Gert-Jan van der Wilt; Ad R M M Hermus; Barto J Otten
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Anca Zimmermann; Paula Grigorescu-Sido; Camelia AlKhzouz; Karen Patberg; Simona Bucerzan; Egbert Schulze; Tim Zimmermann; Heidi Rossmann; Hans-Christian Geiss; Karl J Lackner; Matthias M Weber
Journal:  Horm Res Paediatr       Date:  2010-04-15       Impact factor: 2.852

5.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.

Authors:  E Charmandari; P C Hindmarsh; A Johnston; C G Brook
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

6.  Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.

Authors:  Evangelia Charmandari; Martina Weise; Stefan R Bornstein; Graeme Eisenhofer; Margaret F Keil; George P Chrousos; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

7.  Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Henrik Falhammar; Helena Filipsson; Gundela Holmdahl; Per-Olof Janson; Agneta Nordenskjöld; Kerstin Hagenfeldt; Marja Thorén
Journal:  J Clin Endocrinol Metab       Date:  2006-10-10       Impact factor: 5.958

8.  Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia.

Authors:  F J Paula; L M Gouveia; G M Paccola; C E Piccinato; A C Moreira; M C Foss
Journal:  Horm Metab Res       Date:  1994-11       Impact factor: 2.936

9.  Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.

Authors:  Francesco Fallo; Alessando Scarda; Nicoletta Sonino; Agostino Paoletta; Marco Boscaro; Claudio Pagano; Giovanni Federspil; Roberto Vettor
Journal:  Eur J Endocrinol       Date:  2004-03       Impact factor: 6.664

10.  Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mouna Feki Mnif; Mahdi Kamoun; Fatma Mnif; Nadia Charfi; Basma Ben Naceur; Nozha Kallel; Nabila Rekik; Zainab Mnif; Mohamed Habib Sfar; Mohamed Tahar Sfar; Mongia Hachicha; Mohamed Abid
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more
  9 in total

1.  Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from upper Egypt.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly; Tahra Sherief
Journal:  Eur J Pediatr       Date:  2015-09-21       Impact factor: 3.183

Review 2.  Cardiovascular risk factors and events in women with androgen excess.

Authors:  D Macut; I B Antić; J Bjekić-Macut
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

Review 3.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

4.  Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal Hyperplasia.

Authors:  Mimi S Kim; Anh Dao-Tran; Elana Davidowitz; Teresa Tseng; Vicente Gilsanz; Anna Ryabets-Lienhard; Eugene Nguyen; Mitchell E Geffner
Journal:  Horm Res Paediatr       Date:  2016-03-03       Impact factor: 2.852

5.  Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon.

Authors:  J Tony Nengom; S Sap Ngo Um; D Chelo; R Mbono Betoko; J Boombhi; F Mouafo Tambo; A Chiabi; S Kingue; P Koki Ndombo
Journal:  BMC Pediatr       Date:  2017-04-20       Impact factor: 2.125

Review 6.  Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia.

Authors:  Mimi S Kim; Nicole R Fraga; Nare Minaeian; Mitchell E Geffner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 5.555

Review 7.  Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Authors:  Mattia Barbot; Pierluigi Mazzeo; Martina Lazzara; Filippo Ceccato; Carla Scaroni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

8.  Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.

Authors:  Ahmed Torky; Ninet Sinaii; Smita Jha; Jay Desai; Diala El-Maouche; Ashwini Mallappa; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 5.958

9.  The relationship of carotid intima-media thickness with anthropometric and metabolic parameters in patients with classic congenital adrenal hyperplasia

Authors:  Hale Tuhan; Tülay Öztürk; Gönül Çatlı; Sezer Acar; Ayhan Abacı; Tuğba Egeli; Korcan Demir; Şule Can; Handan Güleryüz; Bumin Dündar; Ece Böber
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.